Wanbury Limited

WANBURY NSE Healthcare Pharmaceuticals
₹239.35
-0.87%
Delayed · cached 15 min

Fair value analysis

WANBURY
Wanbury Limited
HealthcarePharmaceuticals
₹241.45
Close used for this calculation
₹231.77Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
38/100
Profitability6/25
Returns18/25
Balance Sheet1/25
Efficiency13/25
Growth0/25
Average
Quality radar
38Prof.6/25Ret.18/25Eff.13/25B.Sht1/25Growth0/25

Consensus fair value

₹231.77
Near FV
▼ -4.0% against the close used
Model range ₹71.01 – ₹332.72
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹71.01Fair value₹231.77Bull₹332.72
FairClose
52-week traded range
52W low ₹163.3452W high ₹344.75

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading close to the consensus fair value

Wanbury Limited closed at ₹241.45, 4.2% above the consensus fair value of ₹231.77 drawn from 6 valuation models.

Financial DNA score 38/100 — Average. P/E of 19.5x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₹174.68
-27.7%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₹71.01
-70.6%
√(22.5 × EPS × BVPS)
EPS=9.32, BVPS=24.05 · outside Graham range (P/E 19.5, P/B 10) — asset-light, treat as a rough floor
P/E Fair Value
₹332.72
+37.8%
EPS × 35.7x (sector P/E)
EPS=9.32, Sector P/E=35.7x
EV/EBITDA
₹216.64
-10.3%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=930M
Reverse DCF
₹241.45
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 10.6% | Historical: 0%
Margin of Safety
₹144.60
-40.1%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=192.8, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.